About
Jacques Saarbach is a chemical biologist focused on peptide nucleic acids, targeted protein degradation, and induced-proximity drug discovery. He completed PhD work at the University of Geneva in Nicolas Winssinger's lab, then joined Craig Crews's lab at Yale as a Swiss National Science Foundation fellow. He is currently a Principal Scientist at General Proximity and previously contributed as a founding team member to Siduma Therapeutics.
Areas of interest
biotechchemical biologydrug discoverytargeted protein degradationinduced proximitypeptide nucleic acidsmedicinal chemistryprotein dephosphorylationlysosomal degradation